Iron chelates proven less toxic in cancer study
Albion Human Nutrition
Breaking News on Supplements & Nutrition - North AmericaEU edition
Trends > Financial focus
Financial focus
From the financial performance of ingredients companies to mergers and acquisitions that could impact supply or prices, we provide full details of all the latest financial news from companies operating in this dynamic market sector.
Long term trends will continue to drive M&A interest in supplement space, expert says
When Reckitt Benser group outbid Bayer to buy Schiff Nutrition International, members of the investment community sat up and took notice. Did this signal a fundamental shift in how financiers...
Will vitamin C price fixing victory constrain future Chinese cartel behavior?
A longstanding vitamin C price fixing case has reached conclusion with a $162 million judgment in the case involving four Chinese companies. While its a victory for the concept of...
Maturation of fish oil sales leaves supplements seeking next growth driver
The explosive growth of fish oil omega 3s sales has buoyed the dietary supplement sector in recent years. With the fish oil market trending toward maturity, the industry needs a...
Nestlé buys Louisiana depression food firm
Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.
Special edition: Omega-3 (Editor's blog)
How high can high-end omega-3 go?
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted...
UK venture capitalists eye expansion at Israeli antioxidant specialists
Southern Israel-based algae-sourced astanxanthin specialists Algatechnologies has won investment from a UK venture capitalist in a move that will broaden its capacity, R&D and distribution scope for the eye and...
Social media push, discounting to drive GNC in 2013, CEO says
GNC is pushing strongly ahead with a social media marketing campaign to further expand its “unique customer base” said CEO Joe Fortunato in the company’s fourth quarter earnings call. ...
M&A numbers down, but value of deals is up, investment group says
Nutrition Capital Network noted a record 247 deals in the health and wellness sector in 2012. Within that number, the group noted a decline in the number of M&A deals...
Acquisition happy: Naturex 2012 sales up 18.1% in 2012 ; Raisio improves 5.7%
Two leading European ingredients suppliers have bucked hard economic times to post strong results for 2012, with French botanical extracts specialist, Naturex, and Finish agriculture, ingredients and brand owner, Raisio,...
Evolva pays €550,000 for Fluxome resveratrol business
Swiss biotech firm Evolva has bought failing Fluxome’s, yeast-derived resveratrol business for about €550,000 in cash and shares, but says it has no interest in the remaining omega-3 business being...
Reckitt Benckiser-Schiff: Another giant jumps into nutra space
UK-based consumer goods firm Reckitt Benckiser told NutraIngredients today, “nutrition had been on its radar for awhile”, as it plunged $1.4bn (€1.09bn) to outbid German pharma firm Bayer for the US’s second...
Fluxome finds a last-minute buyer: But is it resveratrol or omega-3 to be sold?
Swiss biotech firm Evolva has agreed to buy undisclosed assets from Fluxome, as it leaves its pure pharma research past in the dust and throws the embattled Danish supplier a...
DSM buys Fortitech for €495m; “We are done for awhile”
Rampant nutrition business acquirer, Royal DSM, has splashed the cash for the ninth time in two years – this time to the tune of €495m ($634m) on US-based multinational nutrient...
Q3 wrap: Nutrition stars for DSM and Naturex
Royal DSM saw Q3 sales slip 7% to €2.3bn across all divisions with polymer intermediates performing worst, but as has been the case in recent quarters, the Dutch firm’s nutrition...
Bayer “absolutely open” to further acquisitions after $1.2bn Schiff shop
The consumer arm of German pharma giant Bayer Healthcare is to pay $1.2bn (€920m) for US food supplements company Schiff Nutrition International, a move that will make it one of...
Vitamin price drops but BASF nutrition sees 4% sales growth
BASF’s nutrition and health unit (N&H) earned €492m in Q3 – 4% more for the quarter than in 2011 when it had sales of €471m – despite falling prices for...
Sunwin Stevia International and Wild Flavors GmbH enter global distribution deal
Sunwin USA has ended its distribution deal with Wild Flavors, Inc. to facilitate a global partnership between parent companies Sunwin Stevia International, Inc. and Germany-based Wild Flavors GmbH.
Krill revenues up 23% at Aker Biomarine; Norwegians looking to expand
Krill specialist Aker BioMarine is looking at expanding production after its Q2 results showed operating revenue growth of 23% from NOK87m (€11.91m) in Q2 2011, to NOK107m (€14.65m) in Q2 2012.
‘DMAA issue is behind us’, says Vitamin Shoppe as retailer reports record Q2
Vitamin Shoppe has reported a record second quarter with gross profit increasing 16.3% on the same quarter of last year, with the pre- and post-workout category growing consistently despite the...
Supplement execs have poured $4.5m into Romney’s campaign coffers
Firms and individuals with ties to the nutrition and dietary supplement industry have poured more than $4.5m into Mitt Romney's campaign coffers, according to an analysis conducted by USA TODAY.
Record high amino acid prices should ease in second half, predicts DNP
While the price of some amino acids remains punishingly high, things should ease up later this year as more capacity comes online in China, according to nutraceutical ingredients importer and...
Valensa on astaxanthin dispute with Cyanotech: ‘It is disappointing it has come to this’
It is “disappointing” that two key players in the astaxanthin market have ended up talking via their attorneys after their “excellent business relationship” became frayed, Valensa International president Dr Rudi...
Cyanotech posts 46% hike in sales driven by strong demand for astaxanthin
Hawaii-based microalgae specialist Cyanotech has posted a 46% hike in revenues in fiscal year 2012 to $24.63m driven primarily by an increase in demand for the potent red antioxidant astaxanthin.
Our brand-building strategy is paying off, says Schiff Nutrition boss
Schiff Nutrition’s decision to pump all available cash into branding and innovation instead of deep discounts has paid off for its Move Free joint care brand, with posted a 25%...
Vitamin Shoppe CEO: A lot of CPG companies are looking at the dietary supplements space
Procter & Gamble is probably not the only consumer packaged goods company looking very closely at the dietary supplements sector right now given how much faster it is growing than...
Most Popular News
Key Industry Events
Products
On demand Supplier Webinars
Probiotics: The Path to Better Digestive Health through Quality Clinical Trials
DuPont Nutrition & Health
DuPont Nutrition & Health
